Data / Drug companies / Cyclobenzaprine hydrochloride
Cyclobenzaprine hydrochloride: 61 companies and 223 products in the FDA NDC directory
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Cyclobenzaprine hydrochloride is listed in the FDA National Drug Code Directory by 61 companies, with 223 products in commercial distribution. 208 of the products (93.3%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are tablet, film coated; capsule, extended release; tablet, and the newest product started marketing on October 23, 2026.
The request: Get every company that lists cyclobenzaprine hydrochloride in the FDA NDC directory, with headquarters, website and number of employees. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Companies listing it
- 61
- Products
- 223
- Generic (ANDA) products
- 208 (93.3%)
- Application numbers
- 16
- Routes
- Oral, Sublingual
- Brand names
- Amrix, Tonmya, Fexmid
- openFDA record search
- api.fda.gov
Companies that list cyclobenzaprine hydrochloride
Ranked by number of products. Finished drugs in commercial distribution.
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| Asclemed USA, Inc. | 18 | tablet, film coated; capsule, extended release | Generic drugs (ANDA) | July 20, 2021 |
| NuCare Pharmaceuticals,Inc. | 16 | tablet, film coated | Generic drugs (ANDA) | July 20, 2021 |
| Bryant Ranch Prepack | 15 | tablet, film coated; capsule, extended release | Generic drugs (ANDA) | February 19, 2025 |
| Remedyrepack Inc. | 15 | tablet, film coated; capsule, extended release | Generic drugs (ANDA) | September 13, 2026 |
| A-S Medication Solutions | 11 | tablet, film coated | Generic drugs (ANDA) | July 6, 2020 |
| Preferred Pharmaceuticals Inc. | 10 | tablet, film coated; capsule, extended release | Generic drugs (ANDA) | July 15, 2026 |
| Proficient Rx LP | 7 | tablet, film coated; capsule, extended release | Generic drugs (ANDA) | March 1, 2019 |
| PD-Rx Pharmaceuticals, Inc. | 6 | tablet, film coated | Generic drugs (ANDA) | May 31, 2017 |
| Advanced Rx of Tennessee, LLC | 5 | tablet, film coated; capsule, extended release | Generic drugs (ANDA) | August 8, 2025 |
| Bryant Ranch Prepack | 5 | tablet, film coated; capsule, extended release | Generic drugs (ANDA) | March 4, 2019 |
| Direct_Rx | 5 | tablet, film coated; capsule, extended release | Generic drugs (ANDA) | April 9, 2024 |
| Redpharm Drug | 5 | tablet, film coated | Generic drugs (ANDA) | July 6, 2020 |
| Sportpharm LLC | 5 | tablet, film coated | Generic drugs (ANDA) | July 6, 2020 |
| Teva Pharmaceuticals USA, Inc. | 5 | tablet, film coated; capsule, extended release | Generic drugs (ANDA) | July 20, 2021 |
| Northwind Health Company, LLC | 4 | tablet, film coated | Generic drugs (ANDA) | January 31, 2023 |
| Phoenix RX LLC | 4 | tablet, film coated; capsule, extended release | Generic drugs (ANDA) | March 20, 2025 |
| Advagen Pharma Ltd | 3 | tablet, film coated | Generic drugs (ANDA) | May 31, 2017 |
| AiPing Pharmaceutical, Inc. | 3 | tablet, film coated | Generic drugs (ANDA) | October 23, 2026 |
| Alembic Pharmaceuticals Inc. | 3 | tablet, film coated | Generic drugs (ANDA) | November 4, 2020 |
| Aphena Pharma Solutions - Tennessee, LLC | 3 | tablet, film coated | Generic drugs (ANDA) | April 3, 2020 |
| Coupler LLC | 3 | tablet, film coated | Generic drugs (ANDA) | April 23, 2026 |
| Hawaii Repack, Inc. | 3 | tablet, film coated | Generic drugs (ANDA) | May 31, 2017 |
| Jubilant Cadista Pharmaceuticals Inc. | 3 | tablet, film coated | Generic drugs (ANDA) | October 9, 2017 |
| NorthStar RxLLC | 3 | tablet, film coated | Generic drugs (ANDA) | May 31, 2017 |
| Proficient Rx LP | 3 | tablet, film coated | Generic drugs (ANDA) | March 25, 2015 |
| Rising Pharma Holdings, Inc. | 3 | tablet | Generic drugs (ANDA) | March 10, 2025 |
| St. Mary's Medical Park Pharmacy | 3 | tablet, film coated | Generic drugs (ANDA) | April 9, 2024 |
| TruPharma, LLC | 3 | tablet, film coated | Generic drugs (ANDA) | May 31, 2017 |
| Unichem Pharmaceuticals (USA), Inc. | 3 | tablet, film coated | Generic drugs (ANDA) | July 6, 2020 |
| Amneal Pharmaceuticals LLC | 2 | tablet, film coated | Generic drugs (ANDA) | February 18, 2010 |
| Amneal Pharmaceuticals of New York LLC | 2 | tablet, film coated | Generic drugs (ANDA) | February 18, 2010 |
| Amneal Pharmaceuticals of New York LLC | 2 | capsule, extended release | Authorized generics (NDA) | March 1, 2019 |
| Aurobindo Pharma Limited | 2 | tablet, film coated | Generic drugs (ANDA) | September 26, 2008 |
| Bryant Ranch Prepack | 2 | tablet, film coated | Generic drugs (ANDA) | March 30, 2017 |
| Cephalon, LLC | 2 | capsule, extended release | New drug applications (NDA) | October 2, 2007 |
| Doc Rx | 2 | tablet, film coated; capsule, extended release | Generic drugs (ANDA) | July 31, 2025 |
| KVK-Tech, Inc. | 2 | tablet, film coated | Generic drugs (ANDA) | July 31, 2014 |
| Macleods Pharmaceuticals Limited | 2 | capsule, extended release | Generic drugs (ANDA) | July 22, 2024 |
| Major Pharmaceuticals | 2 | tablet, film coated | Generic drugs (ANDA) | September 26, 2008 |
| Medcore LLC | 2 | tablet, film coated | Generic drugs (ANDA) | January 11, 2026 |
| NCS HealthCare of Ky, LLC DBA Vangard Labs | 2 | tablet, film coated; tablet | Generic drugs (ANDA) | February 19, 2025 |
| QPharma, Inc. | 2 | tablet, film coated | Generic drugs (ANDA) | May 31, 2017 |
| Rising Pharma Holdings, Inc. | 2 | tablet, film coated | Generic drugs (ANDA) | September 26, 2008 |
| Solco Healthcare US, LLC | 2 | tablet, film coated | Generic drugs (ANDA) | March 30, 2017 |
| Upsher-Smith Laboratories, LLC | 2 | capsule, extended release | Generic drugs (ANDA) | March 1, 2019 |
| American Health Packaging | 1 | tablet, film coated | Generic drugs (ANDA) | January 4, 2016 |
| AvKARE | 1 | tablet, film coated | Generic drugs (ANDA) | April 3, 2020 |
| AvPAK | 1 | tablet, film coated | Generic drugs (ANDA) | June 10, 2014 |
| Cardinal Health 107, LLC | 1 | tablet, film coated | Generic drugs (ANDA) | October 10, 2025 |
| Coral Way Pharma, LLC | 1 | tablet, film coated | Generic drugs (ANDA) | October 4, 2026 |
| Direct RX | 1 | tablet, film coated | Generic drugs (ANDA) | August 16, 2019 |
| Golden State Medical Supply, Inc. | 1 | tablet, film coated | Generic drugs (ANDA) | February 28, 2007 |
| Medsource Pharmaceuticals | 1 | tablet, film coated | Generic drugs (ANDA) | September 26, 2008 |
| Northwind Health Company, LLC | 1 | tablet, film coated | Generic drugs (ANDA) | April 29, 2024 |
| PD-Rx Pharmaceuticals, Inc. | 1 | tablet, film coated | Generic drugs (ANDA) | July 31, 2014 |
| Proficient Rx LP | 1 | tablet, film coated | Generic drugs (ANDA) | May 31, 2017 |
| Quality Care Products, LLC | 1 | tablet, film coated | Generic drugs (ANDA) | March 25, 2015 |
| SA3, LLC | 1 | tablet, film coated | Generic drugs (ANDA) | March 25, 2015 |
| Sola Pharmaceuticals, LLC | 1 | tablet, film coated | Generic drugs (ANDA) | July 31, 2025 |
| Tonix Medicines, Inc. | 1 | tablet, orally disintegrating | New drug applications (NDA) | August 15, 2025 |
| Unit Dose Solutions, Inc. | 1 | tablet, film coated | Generic drugs (ANDA) | June 8, 2026 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Tablet, film coated | 186 | 83.4% |
| Capsule, extended release | 30 | 13.5% |
| Tablet | 6 | 2.7% |
| Tablet, orally disintegrating | 1 | 0.4% |
Marketing categories
| Marketing category | Products | Share |
|---|---|---|
| Generic drugs (ANDA) | 208 | 93.3% |
| Authorized generics (NDA) | 12 | 5.4% |
| New drug applications (NDA) | 3 | 1.3% |
Pharmacologic classes
| Class | Products |
|---|---|
| Muscle Relaxant | 223 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.